Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-2”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableLooking for participantsNCT05215704
What this trial is testing

Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV

Who this might be right for
HIV InfectionsHIV-1-infectionHIV-2 Infection
Erasmus Medical Center 40
Not applicableStudy completedNCT01190124
What this trial is testing

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

Who this might be right for
HIV Infections
Doroana, Maria Manuela, M.D. 151
Not applicableStudy completedNCT00097006
What this trial is testing

Retrovirus Epidemiology Donor Study-II (REDS-II)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+10 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT03235310
What this trial is testing

Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention

Who this might be right for
Mother to Child Transmission of HIV
French National Agency for Research on AIDS and Viral Hepatitis 18,200
Not applicableStudy completedNCT00005278
What this trial is testing

Retrovirus Epidemiology Donor Study I (REDS I)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+6 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT04658329
What this trial is testing

Cohorte Nationale VIH-2

Who this might be right for
HIV-2 Infection
ANRS, Emerging Infectious Diseases 1,185
Testing effectiveness (Phase 2)UnknownNCT02441231
What this trial is testing

Probiotic Visbiome for Inflammation and Translocation in HIV II

Who this might be right for
HIV-1 Infection
University Health Network, Toronto 36
Testing effectiveness (Phase 2)Study completedNCT01605890
What this trial is testing

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

Who this might be right for
HIV-2 Infection
ANRS, Emerging Infectious Diseases 30
Testing effectiveness (Phase 2)Study completedNCT03224338
What this trial is testing

Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects

Who this might be right for
HIV II Infection
Blueclinical, Ltd. 30
Not applicableStudy completedNCT00378118
What this trial is testing

Use of OraQuick for Screening HIV in Children Less Than Eighteen Months Old

Who this might be right for
HIV Antibody Testing
Thrasher Research Fund 1,000
Not applicableActive Not RecruitingNCT04888754
What this trial is testing

A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands

Who this might be right for
HIV InfectionsHIV-1-infectionHIV-2 Infection
Erasmus Medical Center 35
Post-approval studies (Phase 4)Study completedNCT02180438
What this trial is testing

An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal

Who this might be right for
HIV-2 Infection
University of Washington 30
Not applicableEnded earlyNCT03394196
What this trial is testing

RESIST-2: 2nd-line ART for HIV-2 Infection

Who this might be right for
HIV-2 Infection
University of Washington 152
Not applicableStudy completedNCT04971343
What this trial is testing

Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol

Who this might be right for
HIV I InfectionHIV-2 Infection
Beckman Coulter, Inc. 8,650
Large-scale testing (Phase 3)Study completedNCT02150993
What this trial is testing

First-Line Treatment for HIV-2

Who this might be right for
HIV-2 Infection
ANRS, Emerging Infectious Diseases 210